Agilent Technologies (A) 39.34 $A
EU5 Cancer Diagnostics Market 2016-2020 - Key Vendors are Abbott, AdnaGen/Alere & Agilent Technologies - Research and Markets
Business Wire - Fri Mar 04, 2:59PM CST
Research and Markets (http://www.researchandmarkets.com/research/bx5vxd/20162020_eu5) has announced the addition of the "2016-2020 EU5 Cancer Diagnostics Market" report to their offering.
A: 39.34 (+0.14)
World Herpes Diagnostic Testing Market 2016-2020: Key Vendors are Abbott, Agilent Technologies, Bio-Rad & Eiken Chemical - Research and Markets
Business Wire - Fri Mar 04, 1:32PM CST
Research and Markets (http://www.researchandmarkets.com/research/dbm4vd/20162020_world) has announced the addition of the "World Herpes Diagnostic Testing Market: Commercial Labs, Hospitals, Physician Offices, Public Health Labs--Supplier Shares, Competitive Strategies, Country Volume and Sales Segment Forecasts" report to their offering.
A: 39.34 (+0.14)
Solid Tumor Testing Market in the US Growth of 11.1% CAGR by 2020 - Analysis, Technologies & Forecast Report 2016-2020 - Key Vendors: Abbott Molecular, Agilent Technologies, Beckman Coulter - Research and Markets
Business Wire - Fri Mar 04, 10:06AM CST
Research and Markets (http://www.researchandmarkets.com/research/qq76mb/solid_tumor) has announced the addition of the "Solid Tumor Testing Market in the US 2016-2020" report to their offering.
A: 39.34 (+0.14)
Global Environmental Testing Market Analysis 2016 - Forecast to 2022 - Key Vendors are ALS Limited, Agilent Technologies & Watercare - Research and Markets
Business Wire - Thu Mar 03, 10:01AM CST
Research and Markets (http://www.researchandmarkets.com/research/2t3cd4/global) has announced the addition of the "Global Environmental Testing Market Analysis 2016 - Forecast to 2022" report to their offering.
A: 39.34 (+0.14)
Global Prenatal Testing and Newborn Screening Market Analysis 2016 - Forecast to 2022 - Agilent Technologies Inc, GE Healthcare & Masimo Corporation are Companies Mentioned - Research and Markets
Business Wire - Thu Mar 03, 9:42AM CST
Research and Markets (http://www.researchandmarkets.com/research/8dcsrp/global_prenatal) has announced the addition of the "Global Prenatal Testing and Newborn Screening Market Analysis 2016 - Forecast to 2022" report to their offering.
MASI: 38.38 (+0.20), A: 39.34 (+0.14)
Canada Cancer Diagnostics Market 2016 - Anticipated Technological Breakthroughs to Create Numerous Opportunities
M2 - Wed Feb 10, 10:53AM CST
Research and Markets (http://www.researchandmarkets.com/research/6sw8lt/2016_canada) has announced the addition of the "2016 Canada Cancer Diagnostics Market - Forecasts, Competitive Strategies, Opportunities for Suppliers" report to their offering. The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further compound the growing demand for malignancy assays and the rapid market expansion. Business Opportunities and Strategic Recommendations: - Specific new product development opportunities with potentially significant - market appeal during the next five years. - Design criteria for new products. - Alternative market penetration strategies. - Potential market entry barriers and risks. Companies Mentioned: - Abbott - AdnaGen/Alere - Agilent Technologies - Applied Gene Technologies - Arca Biopharma - Beckman Coulter/Danaher - Becton Dickinson - Biomedical Diagnostics/Theradiag - bioMerieux - Bio-Rad - CellSearch - Cepheid - Correlogic Systems/Vermillion - Decode Genetics - Diadexus - Diagnocure - Diasorin - Eiken Chemical - Elitech Group - Enterix/Clinical Genomics - (25 Others) For more information visit http://www.researchandmarkets.com/research/6s...016_canada
A: 39.34 (+0.14), CPHD: 33.43 (+0.78), DHR: 90.71 (-0.12)
What's in the Cards for FireEye (FEYE) in Q4 Earnings? (Revised)
Zacks Equity Research - Zacks Investment Research - Wed Feb 10, 8:00AM CST
FireEye Inc. (FEYE) is set to report fourth-quarter 2015 results on Feb 11.
FEYE: 18.25 (+0.05), A: 39.34 (+0.14), AHS: 31.06 (+0.38), PANW: 150.97 (-1.05)
$5.3 Billion Gene Expression Market 2016-2020 by Technology, Consumables, Services & Applications
M2 - Wed Feb 10, 5:09AM CST
Research and Markets (http://www.researchandmarkets.com/research/hw4tfw/gene_expression) has announced the addition of the "Gene Expression Analysis Market - Global Forecasts to 2020" report to their offering. The global gene expression analysis market is projected to grow at a CAGR of 9.3% from 2015 to 2020 to reach 5.30 billion by 2020 The global gene expression analysis market is expected to witness moderate growth in the coming years. The availability of funding, growth in the number of cancer patients, strong focus on research, and the decreasing cost of sequencing are the major factors driving the growth of the gene expression analysis markets. The increasing focus on precision medicines and adoption amongst emerging countries provides attractive/lucrative growth opportunities for the market. However, the high cost of certain instruments poses as a market restraint while the currency devaluation in developing countries poses as challenge for the market. In 2015, the services segment is expected to grow at the fastest CAGR from 2015 to 2020 in the global gene expression analysis market, by type. The insights obtained through gene expression profiling play a vital role in the advancement of disease diagnosis, drug discovery, and precision medicine. This is expected to boost the demand for gene expression profiling services in the coming years. In 2015, North America is expected to account for the largest share of the global gene expression analysis market, followed by Europe, Asia, and the Rest of the World (RoW). Asia-Pacific is expected to be the fastest growing regional segment from 2015 to 2020. North America's large share is attributed to development of gene therapy in the U.S., and focus on gene expression studies to improve the quality of patient care. Increasing research activities on agriculture, government intervention to improve healthcare, and rising popularity of gene expression tests are the factors expected to augment growth in the Asia-Pacific region. The market witnesses high competitive intensity, as there are few large players and several small players. These companies adopt various strategies (agreements, partnerships, joint ventures, collaborations, geographic expansions, new product launches, and acquisitions) to increase their market shares and establish a strong foothold in the global market. Thermo Fisher Scientific, Inc. (U.S.), QIAGEN N.V. (Germany), Illumina, Inc. (U.S.), Bio-Rad Laboratories (U.S.), Agilent Technologies (U.S.), and PerkinElmer (U.S.). are few of the major players in the global gene expression analysis market. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Industry Insights 6 Market Overview 7 Gene Expression Analysis Market, By Consumables 8 Gene Expression Analysis Instruments Market, By Technology 9 Gene Expression Analysis Market, By Service 10 Gene Expression Analysis Market, By Applications 11 Gene Expression Market, By Region 12 Competitive Landscape 13 Company Profiles - Affymetrix, Inc. - Agilent Technologies, Inc. - Bio-Rad Laboratories, Inc. - F. Hoffmann-La Roche Ltd. (Roche) - Ge Healthcare - Illumina, Inc. - Oxford Gene Technology - Perkinelmer, Inc. - Qiagen N.V. - Thermo Fisher Scientific, Inc. For more information visit http://www.researchandmarkets.com/research/hw...expression
A: 39.34 (+0.14), ILMN: 156.14 (-1.31), QGEN: 22.27 (+0.07), AFFX: 13.99 (-0.02)
Will CyberArk Software (CYBR) Surprise in Q4 Earnings?
Zacks Equity Research - Zacks Investment Research - Tue Feb 09, 10:40AM CST
CyberArk Software, Ltd. (CYBR) is set to report fourth-quarter 2015 results on Feb 11.
A: 39.34 (+0.14), CYBR: 39.62 (+1.06), AHS: 31.06 (+0.38), NKTR: 11.35 (-0.09)
What's in the Cards for FireEye (FEYE) in Q4 Earnings?
Zacks Equity Research - Zacks Investment Research - Tue Feb 09, 10:20AM CST
FireEye Inc. (FEYE) is set to report fourth-quarter 2015 results on Feb 11.
FEYE: 18.25 (+0.05), A: 39.34 (+0.14), AHS: 31.06 (+0.38), PANW: 150.97 (-1.05)
What's in Store for Zillow Group (ZG) this Earnings Season?
Zacks Equity Research - Zacks Investment Research - Tue Feb 09, 10:00AM CST
Zillow Group, Inc. (ZG) is set to report fourth-quarter 2015 results on Feb 11.
A: 39.34 (+0.14), ZG: 24.76 (+0.12), AHS: 31.06 (+0.38), AAPL: 103.01 (+1.51)
NetApp (NTAP) to Report Q3 Earnings: What's in Store?
Zacks Equity Research - Zacks Investment Research - Mon Feb 08, 2:25PM CST
NetApp Inc. (NTAP) is set to report third-quarter fiscal 2016 results on Feb 10.
A: 39.34 (+0.14), AHS: 31.06 (+0.38), EMC: 26.31 (-0.01), NTAP: 26.00 (-0.07)
What's in Store for CDW Corp. this Earnings Season?
Zacks Equity Research - Zacks Investment Research - Mon Feb 08, 1:55PM CST
CDW Corporation (CDW) is set to report fourth-quarter fiscal 2015 results on Feb 9.
A: 39.34 (+0.14), AHS: 31.06 (+0.38), NSIT: 26.97 (+0.05), CDW: 40.83 (-0.02)
Paycom Software (PAYC) Q4 Earnings: What's in the Cards?
Zacks Equity Research - Zacks Investment Research - Mon Feb 08, 12:00PM CST
Paycom Software, Inc. (PAYC) is set to report fourth-quarter 2015 results on Feb 9.
PCTY: 31.56 (+0.41), A: 39.34 (+0.14), AHS: 31.06 (+0.38), PAYC: 32.71 (+0.08)
Computer Sciences (CSC) Q3 Earnings: What to Expect?
Zacks Equity Research - Zacks Investment Research - Mon Feb 08, 11:40AM CST
Computer Sciences Corporation (CSC) is set to report fiscal third quarter 2016 results on Feb 9.
T: 37.93 (-0.06), CSC: 30.51 (-0.26), A: 39.34 (+0.14), AHS: 31.06 (+0.38)
33-Country Molecular Diagnostics Market Report - Analysis, Technologies, Opportunities & Forecast 2016-2021 - Key Vendors: Abbott, Arca Biopharma
M2 - Fri Feb 05, 6:37AM CST
Research and Markets (http://www.researchandmarkets.com/research/krshdj/a_33country) has announced the addition of the "A 33-Country Survey of the Molecular Diagnostics Market" report to their offering. This new 33-country survey contains over 1,600 pages, 350 tables, and provides granular data and analysis not available from any other source. The report is designed to help current suppliers and potential market entrants identify and evaluate major business opportunities emerging in the molecular diagnostics market during the next five years. Key Topics Covered: - Supplier sales and market shares in major countries - Five-year test volume and sales forecasts - Strategic profiles of market players and start-up firms developing innovative technologies and products - Emerging technologies - Review of molecular diagnostic analyzers - Specific product and business opportunities for instrument and consumable suppliers The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods. Geographic Coverage: - Australia, Austria, Belgium, Bulgaria, Canada, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Japan, Latvia, Lithuania, Malta, Netherlands, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden, Switzerland, UK, USA Companies Mentioned: - Abbott - Affymetrix - Agilent Technologies - Applied Gene Technologies - Arca Biopharma - Beckman Coulter/Danaher - Becton Dickinson - Biokit - bioMerieux - Bio-Rad - Biotest - CellMark Forensics/LabCorp - Cepheid - Decode Genetics - Diadexus - Eiken - Elitech Group - Enzo - Exact Sciences - Fujirebio - Grifols - Hologic/Gen-Probe - Illumina - Kreatech/Leica - Li-Cor Biosciences - Monogram Biosciences/LabCorp - Myriad Genetics - Ortho-Clinical Diagnostics - Perkin Elmer/Caliper - Proteome Sciences - Qiagen - Roche - Scienion - Sequenom - Shimadzu - Siemens - Sierra Molecular - Takara Bio - Tecan Group - Thermo Fisher For more information visit http://www.researchandmarkets.com/research/kr..._33country
SQNM: 1.57 (+0.10), MYGN: 37.41 (+1.16), A: 39.34 (+0.14), CPHD: 33.43 (+0.78), DHR: 90.71 (-0.12), HOLX: 34.75 (-1.20)
33-Country Survey of the Immunodiagnostics Market - Analysis, Technologies & Forecast Report 2016 - Key Vendors: Abbott, Bayer & Roche
M2 - Thu Feb 04, 10:08AM CST
Research and Markets (http://www.researchandmarkets.com/research/rtd5gz/a_33country) has announced the addition of the "A 33-Country Survey of the Immunodiagnostics Market" report to their offering. This new 33-company survey contains 1,650 pages and 890 tables. The report provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in both centralized (hospitals, commercial laboratories), and POC/decentralized locations. Geographic Coverage: - Australia, Austria, Belgium, Bulgaria, Canada, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Japan, Latvia, Lithuania, Malta, Netherlands, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden, Switzerland, UK, USA Routine Clinical Chemistry: - Albumin, Alkaline Phosphatase, ALT/SGPT, Ammonia, Amylase, AST/SGOT, Bilirubin, BUN (Blood Urea Nitrogen), Calcium, Carbon Dioxide/Bicarbonate, Chloride, Cholesterol, Creatine Kinase (CK), CK-MB, Creatinine, GGT, Glucose, HDL Cholesterol, Homocysteine, Iron, LDH, Magnesium, Phosphorus, Potassium, Sodium, Total Protein, Triglycerides, Troponin, Uric Acid Therapeutic Drug Monitoring (TDM): - Amikacin, Carbamazepine, Cyclosporin, Digoxin, Everolimus, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/Procainamide, Phenobarbital, Phenytoin, Quinidine, Sirolimus, Tacrolimus, Theophylline, Tobramycin, Topirimate, Valproic Acid, Vancomycin Endocrine Function: - Cortisol, Estradiol, FSH, HCG, Gastrin, LH, Progesterone, PTH/IO PTH, Prolactin, T3, T3 Uptake, Free T3, T4, Free T4, TBG, Testosterone, Thyroglobulin Ab, TPO Ab, TSH Tumor Markers and Special Chemistry: - AFP, CA 15-3/27-29, CA 19-9, CEA, Ferritin, Follate (Folic Acid), Glycosylated Hemoglobin, HCG, 25-Hydroxy Vitamin D2 and D3, Occult Blood, PAP, PSA, Thyroglobulin, Vitamin B-12 Drugs of Abuse: - Amphetamines, Barbiturates, Benzodiazepines, Cannabinoids/Marijuana, Cocaine, LSD, Methadone, Methaqualone, Opiates, Phencyclidine (PCP), Propoxyphene, Tricyclic Antidepressants Contains 1,650 pages and 890 tables Companies Mentioned: - Abbott Laboratories - AdnaGen/Alere - Agilent Technologies - Bayer Healthcare - Beckman Coulter/Danaher - Biomedical Diagnostics - BioMerieux - Bio-Rad - DiaSorin - Eiken - Fujirebio - Grifols - Instrumentation Laboratory - Kyowa Medex - Matritech/Alere - Ortho-Clinical Diagnostics - Quest Diagnostics - Roche - Siemens - Sysmex - Thermo Fisher - Tosoh - Wako - Wallac/PE For more information visit http://www.researchandmarkets.com/research/rt..._33country
ABT: 39.18 (+0.36), A: 39.34 (+0.14), DGX: 69.32 (-0.39), DHR: 90.71 (-0.12)
Canada Molecular Diagnostics Market 2016: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing
M2 - Wed Feb 03, 9:35AM CST
Research and Markets (http://www.researchandmarkets.com/research/psx4dl/2016_canada) has announced the addition of the "2016 Canada Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies and Opportunities for Suppliers" report to their offering. This new report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the molecular diagnostics market during the next five years. The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods. In order to successfully capitalize on the opportunities presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years. Highlights - Five-year test volume and sales forecasts - Feature comparison of major analyzers - Profiles of market players and start-up firms developing innovative technologies and products - Specific product and business opportunities for instrument and consumable suppliers. Companies Mentioned - Abbott - Affymetrix - Agilent Technologies - Applied Gene Technologies - Arca Biopharma - Beckman Coulter/Danaher - Becton Dickinson - Biokit - bioMerieux - Bio-Rad - Biotest - CellMark Forensics/LabCorp - Cepheid - Decode Genetics - Diadexus - Eiken - Elitech Group - Enzo - Exact Sciences - Fujirebio - Grifols - Hologic/Gen-Probe - Ortho-Clinical Diagnostics - Perkin Elmer/Caliper - Proteome Sciences - Qiagen - Roche - Scienion - Sequenom - Shimadzu - Siemens - Sierra Molecular - Takara Bio - Tecan Group - Thermo Fisher For more information visit http://www.researchandmarkets.com/research/ps...016_canada
SQNM: 1.57 (+0.10), A: 39.34 (+0.14), CPHD: 33.43 (+0.78), DHR: 90.71 (-0.12), HOLX: 34.75 (-1.20)
2016 POC/Decentralized Coagulation Testing Market Report
M2 - Wed Feb 03, 9:29AM CST
Research and Markets (http://www.researchandmarkets.com/research/8lwr7t/2016) has announced the addition of the "2016 POC/Decentralized Coagulation Testing Market: Physician Offices, Emergency Rooms, Operating Suites, ICUs/CCUs, Cancer Clinics, Ambulatory Care Centers, Surgery Centers, Nursing Homes, Birth Centers" report to their offering. This new 450-page report contains 53 tables, and provides a comprehensive analysis of the POC coagulation testing market, including trends, dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. This report will help diagnostic product suppliers develop effective business, R&D and marketing strategies for the global POC coagulation market. The growing economic pressures on hospitals, coupled with advances in diagnostic technologies, intensifying competition among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals and commercial laboratories closer to the patient. Market Segmentation Analysis - Review of nine POC market segments, including their dynamics, trends, structure, size, growth and major suppliers. Five-year test volume and reagent sales forecasts for coagulation procedures by market segment: - Physician Offices/Group Practices - Emergency Rooms - Operating/Recovery Suites - ICUs/CCUs - Cancer Clinics - Ambulatory Care Centers - Surgery Centers - Nursing Homes - Birth Centers Companies Mentioned - Abbott - ADI/American Diagnostica/Sekisui - Agilent Technologies - Alere/Biosite/Inverness - Axis-Shield - Beckman Coulter/Danaher - Becton Dickinson - Bio/Data - Biomerieux - Corgenix - Decode Genetics - Diadexus - Diagnocure - Diagnostica Stago/Trinity Biotech - Diamedix - Diasorin - Eiken Chemical - EKF Diagnostics - Fujirebio - Grifols - Helena Laboratories - Hologic/Gen-Probe - Horiba - Instrumentation Laboratory - International Technidyne/Nexus DX - Kreatech/Leica - Kyowa Medex - Lonza - Qiagen - Roche - Siemens - Sienco - Sysmex - Takara Bio - ThermoFisher For more information visit http://www.researchandmarkets.com/research/8lwr7t/2016
A: 39.34 (+0.14), DHR: 90.71 (-0.12), HOLX: 34.75 (-1.20)
U.S. POC/Decentralized Hematology and Flow Cytometry Markets Report 2016
M2 - Wed Feb 03, 9:29AM CST
Research and Markets (http://www.researchandmarkets.com/research/zt3qx4/2016_u_s) has announced the addition of the "2016 U.S. POC/Decentralized Hematology and Flow Cytometry Markets: Physician Offices, Emergency Rooms, Operating Suites, ICUs/CCUs, Cancer Clinics, Ambulatory Care Centers, Surgery Centers, Nursing Homes, Birth Centers" report to their offering. This new 238-page report contains 38 tables, and provides a comprehensive analysis of the POC hematology and flow cytometry market, including trends, dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. This report will help diagnostic product suppliers develop effective business, R&D and marketing strategies for the global POC hematology and flow cytometry market. The growing economic pressures on hospitals, coupled with advances in diagnostic technologies, intensifying competition among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals and commercial laboratories closer to the patient. Market Segmentation Analysis - Review of nine POC market segments, including their dynamics, trends, structure, size, growth and major suppliers. Five-year test volume and reagent sales forecasts for hematology and flow cytometry procedures by market segment: - Physician Offices/Group Practices - Emergency Rooms - Operating/Recovery Suites - ICUs/CCUs - Cancer Clinics - Ambulatory Care Centers - Surgery Centers - Nursing Homes - Birth Centers Companies Mentioned - Abbott - Agilent Technologies - Beckman Coulter/Danaher - Becton Dickinson - Bio-Rad - CellaVision - Horiba - Iris Diagnostics/Danaher - Nihon Kohden - Ortho-Clinical Diagnostics - Roche - Siemens - Sysmex For more information visit http://www.researchandmarkets.com/research/zt3qx4/2016_u_s
A: 39.34 (+0.14), DHR: 90.71 (-0.12)
EU5 Cancer Diagnostics Market 2016-2020 - Key Vendors are Abbott, AdnaGen/Alere & Agilent Technologies - Research and Markets
Business Wire - Fri Mar 04, 2:59PM CST
Research and Markets (http://www.researchandmarkets.com/research/bx5vxd/20162020_eu5) has announced the addition of the "2016-2020 EU5 Cancer Diagnostics Market" report to their offering.
A: 39.34 (+0.14)
World Herpes Diagnostic Testing Market 2016-2020: Key Vendors are Abbott, Agilent Technologies, Bio-Rad & Eiken Chemical - Research and Markets
Business Wire - Fri Mar 04, 1:32PM CST
Research and Markets (http://www.researchandmarkets.com/research/dbm4vd/20162020_world) has announced the addition of the "World Herpes Diagnostic Testing Market: Commercial Labs, Hospitals, Physician Offices, Public Health Labs--Supplier Shares, Competitive Strategies, Country Volume and Sales Segment Forecasts" report to their offering.
A: 39.34 (+0.14)
Solid Tumor Testing Market in the US Growth of 11.1% CAGR by 2020 - Analysis, Technologies & Forecast Report 2016-2020 - Key Vendors: Abbott Molecular, Agilent Technologies, Beckman Coulter - Research and Markets
Business Wire - Fri Mar 04, 10:06AM CST
Research and Markets (http://www.researchandmarkets.com/research/qq76mb/solid_tumor) has announced the addition of the "Solid Tumor Testing Market in the US 2016-2020" report to their offering.
A: 39.34 (+0.14)
Global Environmental Testing Market Analysis 2016 - Forecast to 2022 - Key Vendors are ALS Limited, Agilent Technologies & Watercare - Research and Markets
Business Wire - Thu Mar 03, 10:01AM CST
Research and Markets (http://www.researchandmarkets.com/research/2t3cd4/global) has announced the addition of the "Global Environmental Testing Market Analysis 2016 - Forecast to 2022" report to their offering.
A: 39.34 (+0.14)
Global Prenatal Testing and Newborn Screening Market Analysis 2016 - Forecast to 2022 - Agilent Technologies Inc, GE Healthcare & Masimo Corporation are Companies Mentioned - Research and Markets
Business Wire - Thu Mar 03, 9:42AM CST
Research and Markets (http://www.researchandmarkets.com/research/8dcsrp/global_prenatal) has announced the addition of the "Global Prenatal Testing and Newborn Screening Market Analysis 2016 - Forecast to 2022" report to their offering.
MASI: 38.38 (+0.20), A: 39.34 (+0.14)
Canada Cancer Diagnostics Market 2016 - Anticipated Technological Breakthroughs to Create Numerous Opportunities
M2 - Wed Feb 10, 10:53AM CST
Research and Markets (http://www.researchandmarkets.com/research/6sw8lt/2016_canada) has announced the addition of the "2016 Canada Cancer Diagnostics Market - Forecasts, Competitive Strategies, Opportunities for Suppliers" report to their offering. The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further compound the growing demand for malignancy assays and the rapid market expansion. Business Opportunities and Strategic Recommendations: - Specific new product development opportunities with potentially significant - market appeal during the next five years. - Design criteria for new products. - Alternative market penetration strategies. - Potential market entry barriers and risks. Companies Mentioned: - Abbott - AdnaGen/Alere - Agilent Technologies - Applied Gene Technologies - Arca Biopharma - Beckman Coulter/Danaher - Becton Dickinson - Biomedical Diagnostics/Theradiag - bioMerieux - Bio-Rad - CellSearch - Cepheid - Correlogic Systems/Vermillion - Decode Genetics - Diadexus - Diagnocure - Diasorin - Eiken Chemical - Elitech Group - Enterix/Clinical Genomics - (25 Others) For more information visit http://www.researchandmarkets.com/research/6s...016_canada
A: 39.34 (+0.14), CPHD: 33.43 (+0.78), DHR: 90.71 (-0.12)
What's in the Cards for FireEye (FEYE) in Q4 Earnings? (Revised)
Zacks Equity Research - Zacks Investment Research - Wed Feb 10, 8:00AM CST
FireEye Inc. (FEYE) is set to report fourth-quarter 2015 results on Feb 11.
FEYE: 18.25 (+0.05), A: 39.34 (+0.14), AHS: 31.06 (+0.38), PANW: 150.97 (-1.05)
$5.3 Billion Gene Expression Market 2016-2020 by Technology, Consumables, Services & Applications
M2 - Wed Feb 10, 5:09AM CST
Research and Markets (http://www.researchandmarkets.com/research/hw4tfw/gene_expression) has announced the addition of the "Gene Expression Analysis Market - Global Forecasts to 2020" report to their offering. The global gene expression analysis market is projected to grow at a CAGR of 9.3% from 2015 to 2020 to reach 5.30 billion by 2020 The global gene expression analysis market is expected to witness moderate growth in the coming years. The availability of funding, growth in the number of cancer patients, strong focus on research, and the decreasing cost of sequencing are the major factors driving the growth of the gene expression analysis markets. The increasing focus on precision medicines and adoption amongst emerging countries provides attractive/lucrative growth opportunities for the market. However, the high cost of certain instruments poses as a market restraint while the currency devaluation in developing countries poses as challenge for the market. In 2015, the services segment is expected to grow at the fastest CAGR from 2015 to 2020 in the global gene expression analysis market, by type. The insights obtained through gene expression profiling play a vital role in the advancement of disease diagnosis, drug discovery, and precision medicine. This is expected to boost the demand for gene expression profiling services in the coming years. In 2015, North America is expected to account for the largest share of the global gene expression analysis market, followed by Europe, Asia, and the Rest of the World (RoW). Asia-Pacific is expected to be the fastest growing regional segment from 2015 to 2020. North America's large share is attributed to development of gene therapy in the U.S., and focus on gene expression studies to improve the quality of patient care. Increasing research activities on agriculture, government intervention to improve healthcare, and rising popularity of gene expression tests are the factors expected to augment growth in the Asia-Pacific region. The market witnesses high competitive intensity, as there are few large players and several small players. These companies adopt various strategies (agreements, partnerships, joint ventures, collaborations, geographic expansions, new product launches, and acquisitions) to increase their market shares and establish a strong foothold in the global market. Thermo Fisher Scientific, Inc. (U.S.), QIAGEN N.V. (Germany), Illumina, Inc. (U.S.), Bio-Rad Laboratories (U.S.), Agilent Technologies (U.S.), and PerkinElmer (U.S.). are few of the major players in the global gene expression analysis market. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Industry Insights 6 Market Overview 7 Gene Expression Analysis Market, By Consumables 8 Gene Expression Analysis Instruments Market, By Technology 9 Gene Expression Analysis Market, By Service 10 Gene Expression Analysis Market, By Applications 11 Gene Expression Market, By Region 12 Competitive Landscape 13 Company Profiles - Affymetrix, Inc. - Agilent Technologies, Inc. - Bio-Rad Laboratories, Inc. - F. Hoffmann-La Roche Ltd. (Roche) - Ge Healthcare - Illumina, Inc. - Oxford Gene Technology - Perkinelmer, Inc. - Qiagen N.V. - Thermo Fisher Scientific, Inc. For more information visit http://www.researchandmarkets.com/research/hw...expression
A: 39.34 (+0.14), ILMN: 156.14 (-1.31), QGEN: 22.27 (+0.07), AFFX: 13.99 (-0.02)
Will CyberArk Software (CYBR) Surprise in Q4 Earnings?
Zacks Equity Research - Zacks Investment Research - Tue Feb 09, 10:40AM CST
CyberArk Software, Ltd. (CYBR) is set to report fourth-quarter 2015 results on Feb 11.
A: 39.34 (+0.14), CYBR: 39.62 (+1.06), AHS: 31.06 (+0.38), NKTR: 11.35 (-0.09)
What's in the Cards for FireEye (FEYE) in Q4 Earnings?
Zacks Equity Research - Zacks Investment Research - Tue Feb 09, 10:20AM CST
FireEye Inc. (FEYE) is set to report fourth-quarter 2015 results on Feb 11.
FEYE: 18.25 (+0.05), A: 39.34 (+0.14), AHS: 31.06 (+0.38), PANW: 150.97 (-1.05)
What's in Store for Zillow Group (ZG) this Earnings Season?
Zacks Equity Research - Zacks Investment Research - Tue Feb 09, 10:00AM CST
Zillow Group, Inc. (ZG) is set to report fourth-quarter 2015 results on Feb 11.
A: 39.34 (+0.14), ZG: 24.76 (+0.12), AHS: 31.06 (+0.38), AAPL: 103.01 (+1.51)
NetApp (NTAP) to Report Q3 Earnings: What's in Store?
Zacks Equity Research - Zacks Investment Research - Mon Feb 08, 2:25PM CST
NetApp Inc. (NTAP) is set to report third-quarter fiscal 2016 results on Feb 10.
A: 39.34 (+0.14), AHS: 31.06 (+0.38), EMC: 26.31 (-0.01), NTAP: 26.00 (-0.07)
What's in Store for CDW Corp. this Earnings Season?
Zacks Equity Research - Zacks Investment Research - Mon Feb 08, 1:55PM CST
CDW Corporation (CDW) is set to report fourth-quarter fiscal 2015 results on Feb 9.
A: 39.34 (+0.14), AHS: 31.06 (+0.38), NSIT: 26.97 (+0.05), CDW: 40.83 (-0.02)
Paycom Software (PAYC) Q4 Earnings: What's in the Cards?
Zacks Equity Research - Zacks Investment Research - Mon Feb 08, 12:00PM CST
Paycom Software, Inc. (PAYC) is set to report fourth-quarter 2015 results on Feb 9.
PCTY: 31.56 (+0.41), A: 39.34 (+0.14), AHS: 31.06 (+0.38), PAYC: 32.71 (+0.08)
Computer Sciences (CSC) Q3 Earnings: What to Expect?
Zacks Equity Research - Zacks Investment Research - Mon Feb 08, 11:40AM CST
Computer Sciences Corporation (CSC) is set to report fiscal third quarter 2016 results on Feb 9.
T: 37.93 (-0.06), CSC: 30.51 (-0.26), A: 39.34 (+0.14), AHS: 31.06 (+0.38)
33-Country Molecular Diagnostics Market Report - Analysis, Technologies, Opportunities & Forecast 2016-2021 - Key Vendors: Abbott, Arca Biopharma
M2 - Fri Feb 05, 6:37AM CST
Research and Markets (http://www.researchandmarkets.com/research/krshdj/a_33country) has announced the addition of the "A 33-Country Survey of the Molecular Diagnostics Market" report to their offering. This new 33-country survey contains over 1,600 pages, 350 tables, and provides granular data and analysis not available from any other source. The report is designed to help current suppliers and potential market entrants identify and evaluate major business opportunities emerging in the molecular diagnostics market during the next five years. Key Topics Covered: - Supplier sales and market shares in major countries - Five-year test volume and sales forecasts - Strategic profiles of market players and start-up firms developing innovative technologies and products - Emerging technologies - Review of molecular diagnostic analyzers - Specific product and business opportunities for instrument and consumable suppliers The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods. Geographic Coverage: - Australia, Austria, Belgium, Bulgaria, Canada, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Japan, Latvia, Lithuania, Malta, Netherlands, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden, Switzerland, UK, USA Companies Mentioned: - Abbott - Affymetrix - Agilent Technologies - Applied Gene Technologies - Arca Biopharma - Beckman Coulter/Danaher - Becton Dickinson - Biokit - bioMerieux - Bio-Rad - Biotest - CellMark Forensics/LabCorp - Cepheid - Decode Genetics - Diadexus - Eiken - Elitech Group - Enzo - Exact Sciences - Fujirebio - Grifols - Hologic/Gen-Probe - Illumina - Kreatech/Leica - Li-Cor Biosciences - Monogram Biosciences/LabCorp - Myriad Genetics - Ortho-Clinical Diagnostics - Perkin Elmer/Caliper - Proteome Sciences - Qiagen - Roche - Scienion - Sequenom - Shimadzu - Siemens - Sierra Molecular - Takara Bio - Tecan Group - Thermo Fisher For more information visit http://www.researchandmarkets.com/research/kr..._33country
SQNM: 1.57 (+0.10), MYGN: 37.41 (+1.16), A: 39.34 (+0.14), CPHD: 33.43 (+0.78), DHR: 90.71 (-0.12), HOLX: 34.75 (-1.20)
33-Country Survey of the Immunodiagnostics Market - Analysis, Technologies & Forecast Report 2016 - Key Vendors: Abbott, Bayer & Roche
M2 - Thu Feb 04, 10:08AM CST
Research and Markets (http://www.researchandmarkets.com/research/rtd5gz/a_33country) has announced the addition of the "A 33-Country Survey of the Immunodiagnostics Market" report to their offering. This new 33-company survey contains 1,650 pages and 890 tables. The report provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in both centralized (hospitals, commercial laboratories), and POC/decentralized locations. Geographic Coverage: - Australia, Austria, Belgium, Bulgaria, Canada, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Japan, Latvia, Lithuania, Malta, Netherlands, Norway, Poland, Portugal, Romania, Slovakia, Slovenia, Spain, Sweden, Switzerland, UK, USA Routine Clinical Chemistry: - Albumin, Alkaline Phosphatase, ALT/SGPT, Ammonia, Amylase, AST/SGOT, Bilirubin, BUN (Blood Urea Nitrogen), Calcium, Carbon Dioxide/Bicarbonate, Chloride, Cholesterol, Creatine Kinase (CK), CK-MB, Creatinine, GGT, Glucose, HDL Cholesterol, Homocysteine, Iron, LDH, Magnesium, Phosphorus, Potassium, Sodium, Total Protein, Triglycerides, Troponin, Uric Acid Therapeutic Drug Monitoring (TDM): - Amikacin, Carbamazepine, Cyclosporin, Digoxin, Everolimus, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/Procainamide, Phenobarbital, Phenytoin, Quinidine, Sirolimus, Tacrolimus, Theophylline, Tobramycin, Topirimate, Valproic Acid, Vancomycin Endocrine Function: - Cortisol, Estradiol, FSH, HCG, Gastrin, LH, Progesterone, PTH/IO PTH, Prolactin, T3, T3 Uptake, Free T3, T4, Free T4, TBG, Testosterone, Thyroglobulin Ab, TPO Ab, TSH Tumor Markers and Special Chemistry: - AFP, CA 15-3/27-29, CA 19-9, CEA, Ferritin, Follate (Folic Acid), Glycosylated Hemoglobin, HCG, 25-Hydroxy Vitamin D2 and D3, Occult Blood, PAP, PSA, Thyroglobulin, Vitamin B-12 Drugs of Abuse: - Amphetamines, Barbiturates, Benzodiazepines, Cannabinoids/Marijuana, Cocaine, LSD, Methadone, Methaqualone, Opiates, Phencyclidine (PCP), Propoxyphene, Tricyclic Antidepressants Contains 1,650 pages and 890 tables Companies Mentioned: - Abbott Laboratories - AdnaGen/Alere - Agilent Technologies - Bayer Healthcare - Beckman Coulter/Danaher - Biomedical Diagnostics - BioMerieux - Bio-Rad - DiaSorin - Eiken - Fujirebio - Grifols - Instrumentation Laboratory - Kyowa Medex - Matritech/Alere - Ortho-Clinical Diagnostics - Quest Diagnostics - Roche - Siemens - Sysmex - Thermo Fisher - Tosoh - Wako - Wallac/PE For more information visit http://www.researchandmarkets.com/research/rt..._33country
ABT: 39.18 (+0.36), A: 39.34 (+0.14), DGX: 69.32 (-0.39), DHR: 90.71 (-0.12)
Canada Molecular Diagnostics Market 2016: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing
M2 - Wed Feb 03, 9:35AM CST
Research and Markets (http://www.researchandmarkets.com/research/psx4dl/2016_canada) has announced the addition of the "2016 Canada Molecular Diagnostics Market: Infectious Diseases, Genetic Diseases, Cancer, Forensic and Paternity Testing--Test Volume and Sales Segment Forecasts, Competitive Strategies and Opportunities for Suppliers" report to their offering. This new report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the molecular diagnostics market during the next five years. The molecular diagnostics market is unquestionably the most rapidly growing segment of the in vitro diagnostics industry. The next five years will witness significant developments in reagent systems and automation, as well as introduction of a wide range of new products that will require innovative marketing approaches. The rate of market penetration into routine clinical laboratories, however, will depend on the introduction of cost-effective and automated systems with amplification methods. In order to successfully capitalize on the opportunities presented by the molecular diagnostics market, many companies are already exploiting new molecular technologies as corporate strategic assets, managed in support of business and marketing strategies. Integrating new technology planning with business and corporate strategies will be one of the most challenging tasks for diagnostic companies during the next five years. Highlights - Five-year test volume and sales forecasts - Feature comparison of major analyzers - Profiles of market players and start-up firms developing innovative technologies and products - Specific product and business opportunities for instrument and consumable suppliers. Companies Mentioned - Abbott - Affymetrix - Agilent Technologies - Applied Gene Technologies - Arca Biopharma - Beckman Coulter/Danaher - Becton Dickinson - Biokit - bioMerieux - Bio-Rad - Biotest - CellMark Forensics/LabCorp - Cepheid - Decode Genetics - Diadexus - Eiken - Elitech Group - Enzo - Exact Sciences - Fujirebio - Grifols - Hologic/Gen-Probe - Ortho-Clinical Diagnostics - Perkin Elmer/Caliper - Proteome Sciences - Qiagen - Roche - Scienion - Sequenom - Shimadzu - Siemens - Sierra Molecular - Takara Bio - Tecan Group - Thermo Fisher For more information visit http://www.researchandmarkets.com/research/ps...016_canada
SQNM: 1.57 (+0.10), A: 39.34 (+0.14), CPHD: 33.43 (+0.78), DHR: 90.71 (-0.12), HOLX: 34.75 (-1.20)
2016 POC/Decentralized Coagulation Testing Market Report
M2 - Wed Feb 03, 9:29AM CST
Research and Markets (http://www.researchandmarkets.com/research/8lwr7t/2016) has announced the addition of the "2016 POC/Decentralized Coagulation Testing Market: Physician Offices, Emergency Rooms, Operating Suites, ICUs/CCUs, Cancer Clinics, Ambulatory Care Centers, Surgery Centers, Nursing Homes, Birth Centers" report to their offering. This new 450-page report contains 53 tables, and provides a comprehensive analysis of the POC coagulation testing market, including trends, dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. This report will help diagnostic product suppliers develop effective business, R&D and marketing strategies for the global POC coagulation market. The growing economic pressures on hospitals, coupled with advances in diagnostic technologies, intensifying competition among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals and commercial laboratories closer to the patient. Market Segmentation Analysis - Review of nine POC market segments, including their dynamics, trends, structure, size, growth and major suppliers. Five-year test volume and reagent sales forecasts for coagulation procedures by market segment: - Physician Offices/Group Practices - Emergency Rooms - Operating/Recovery Suites - ICUs/CCUs - Cancer Clinics - Ambulatory Care Centers - Surgery Centers - Nursing Homes - Birth Centers Companies Mentioned - Abbott - ADI/American Diagnostica/Sekisui - Agilent Technologies - Alere/Biosite/Inverness - Axis-Shield - Beckman Coulter/Danaher - Becton Dickinson - Bio/Data - Biomerieux - Corgenix - Decode Genetics - Diadexus - Diagnocure - Diagnostica Stago/Trinity Biotech - Diamedix - Diasorin - Eiken Chemical - EKF Diagnostics - Fujirebio - Grifols - Helena Laboratories - Hologic/Gen-Probe - Horiba - Instrumentation Laboratory - International Technidyne/Nexus DX - Kreatech/Leica - Kyowa Medex - Lonza - Qiagen - Roche - Siemens - Sienco - Sysmex - Takara Bio - ThermoFisher For more information visit http://www.researchandmarkets.com/research/8lwr7t/2016
A: 39.34 (+0.14), DHR: 90.71 (-0.12), HOLX: 34.75 (-1.20)
U.S. POC/Decentralized Hematology and Flow Cytometry Markets Report 2016
M2 - Wed Feb 03, 9:29AM CST
Research and Markets (http://www.researchandmarkets.com/research/zt3qx4/2016_u_s) has announced the addition of the "2016 U.S. POC/Decentralized Hematology and Flow Cytometry Markets: Physician Offices, Emergency Rooms, Operating Suites, ICUs/CCUs, Cancer Clinics, Ambulatory Care Centers, Surgery Centers, Nursing Homes, Birth Centers" report to their offering. This new 238-page report contains 38 tables, and provides a comprehensive analysis of the POC hematology and flow cytometry market, including trends, dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. This report will help diagnostic product suppliers develop effective business, R&D and marketing strategies for the global POC hematology and flow cytometry market. The growing economic pressures on hospitals, coupled with advances in diagnostic technologies, intensifying competition among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals and commercial laboratories closer to the patient. Market Segmentation Analysis - Review of nine POC market segments, including their dynamics, trends, structure, size, growth and major suppliers. Five-year test volume and reagent sales forecasts for hematology and flow cytometry procedures by market segment: - Physician Offices/Group Practices - Emergency Rooms - Operating/Recovery Suites - ICUs/CCUs - Cancer Clinics - Ambulatory Care Centers - Surgery Centers - Nursing Homes - Birth Centers Companies Mentioned - Abbott - Agilent Technologies - Beckman Coulter/Danaher - Becton Dickinson - Bio-Rad - CellaVision - Horiba - Iris Diagnostics/Danaher - Nihon Kohden - Ortho-Clinical Diagnostics - Roche - Siemens - Sysmex For more information visit http://www.researchandmarkets.com/research/zt3qx4/2016_u_s
A: 39.34 (+0.14), DHR: 90.71 (-0.12)
